In the kidney, the inhibition of TGF-β signaling is also associated with decreased epithelial mesenchymal transition (EMT) and the accumulation of myofibroblasts in the kidney, thus reducing renal fibrosis and the progression of chronic kidney injury [56]. Here, TGFB1 is linked to renal fibrosis.